AccessHope Expands Cancer Care Offerings with New AI Capabilities, Supportive Oncology, Clinical Trials, and International Expert Reviews

2026-11-12 · Source: PR Newswire Insurance

Summary in 3 Points • AccessHope's model reduces average total cost of care by 10% to 30% per adopted recommendation in one year. • The company delivers an average of $32,000 in annual total cost of care savings per patient with adopted recommendations. • AccessHope serves over 10 million members through partnerships with over 800 organizations, including more than 80 Fortune 500 companies. --- AccessHope has announced enhancements to its cancer expertise model, integrating AI capabilities and expanding clinical trials. The model has been shown to reduce the average total cost of care by 10% to 30% per adopted recommendation, with an average savings of $32,000 per patient annually. This is achieved by providing evidence-based subspecialist guidance to community oncologists, improving treatment quality and outcomes while lowering costs. The company's methodology has been independently validated, reflecting over six years of utilization experience. AccessHope aims to strengthen community oncology by delivering subspecialty expertise directly to care teams at critical moments. This approach addresses the challenge that only 20% of cancer patients receive treatment at National Cancer Institute-designated Comprehensive Cancer Centers, ensuring that community oncologists have access to the latest advancements in cancer care. AccessHope's model can impact the cancer insurance line by reducing costs through evidence-based recommendations, potentially influencing claims management processes.

London market impact

AccessHope's model can impact the cancer insurance line by reducing costs through evidence-based recommendations, potentially influencing claims management processes.